KUALA LUMPUR, June 12 — Communications Minister Datuk Fahmi Fadzil said a total of 1.88 million Malaysians have be...KUALA LUMPUR, June 12 — Communications Minister Datuk Fahmi Fadzil said a total of 1.88 million Malaysians have be...

Hospitalisation, critical illness and medical device aid among RM1.42b MySalam payouts to Malaysians, says minister

2026/06/12 17:07
1 min read
For feedback or concerns regarding this content, please contact us at [email protected]

KUALA LUMPUR, June 12 — Communications Minister Datuk Fahmi Fadzil said a total of 1.88 million Malaysians have benefited from the MySalam health protection scheme since its introduction in 2019, with claims amounting to RM1.423 billion as at December 31, 2025.

He said eligible recipients comprise beneficiaries of the Sumbangan Tunai Rahmah (STR) programme and their spouses aged up to 65.

“Beneficiaries are entitled to three forms of assistance. 

“The first is a hospitalisation benefit of RM50 per day for up to 14 days annually, with a maximum annual payment of RM700,” he said during the ministry’s weekly press conference here today.

The second benefit, he explained, is a one-off payment of up to RM8,000 for recipients diagnosed with any of the 50 listed critical illnesses.

Fahmi also said beneficiaries are entitled to a medical device benefit of up to RM30,000.

According to figures presented to the Cabinet, he said over 1.294 million recipients have received hospitalisation benefits amounting to RM394.87 million.

“For critical illness claims, 89,085 recipients received payments amounting to RM712.68 million.

For medical device assistance, 13,128 recipients received support worth RM65.257 million,” he added.

Predict & Trade to Win Rewards

Predict & Trade to Win RewardsPredict & Trade to Win Rewards

Guaranteed rewards with $500,000 prize pool

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

RealStocks Now Live

RealStocks Now LiveRealStocks Now Live

Trade real U.S. stock via regulated brokerage